Related Experiment Video
Updated: Jul 20, 2026
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
Identification of Cancer Antigens in Breast Cancer by the SEREX Expression Cloning Method
1Laboratory of Immunology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan.
Abstract:
Enormous strides in cancer immunology have been made during the past decade. This is largely due to the development of methodologies capable of defining the antigenic targets on cancer cells that elicit a host immune response. The molecular cloning of antigens recognized by cytotoxic T cells by Boon and his colleagues has provided a growing list of tumor antigens, particularly for melanoma, that allows detailed monitoring of T cell responses to these antigens and offers promising targets for cancer vaccine development. An alternative new method, SEREX, for the serological identification of cancer antigens has been developed by Pfreundschuh and his colleagues. SEREX can be applied to all types of cancer including breast cancer that have been unapproachable by using cytotoxic T cells and thus offers an opportunity to define a vast range of cancer antigens. Toward thedevelopment of a vaccine for breast cancer, we have begun using SEREX to study breast cancer and have identified a few promising cancer antigens. Each antigen is now being critically evaluated as a possible vaccine target.
Insights
Researchers are identifying novel cancer antigens for breast cancer vaccines using the SEREX method. This approach targets tumor antigens to elicit an immune response, offering new hope for effective cancer immunotherapy.
Area of Science:
- Cancer Immunology
- Molecular Biology
Background:
- Recent advancements in cancer immunology rely on identifying antigenic targets on cancer cells.
- Cytotoxic T cell-recognized tumor antigens, particularly for melanoma, aid in monitoring T cell responses and developing cancer vaccines.
Purpose of the Study:
- To develop a vaccine for breast cancer by identifying promising cancer antigens.
- To utilize the SEREX (serological identification of cancer antigens) method for breast cancer research.
Main Methods:
- Employed the SEREX method for the serological identification of cancer antigens.
- Applied SEREX to breast cancer, a type previously difficult to target with cytotoxic T cells.
Main Results:
- Identified several promising cancer antigens specific to breast cancer.
- These antigens are currently under evaluation as potential vaccine targets.
Conclusions:
- The SEREX method provides a viable approach to define a wide range of cancer antigens, including those in breast cancer.
- The identified antigens represent promising candidates for future breast cancer vaccine development.
